What to know
Translational Genomics Research Institute (TGen North) expanded their analysis of SARS-CoV-2 genomic diversity and provided information on how the SARS-CoV-2 spreads and evolves. Awarded in 2021, this project conducted multilevel genomic analysis on COVID-19 clinical sample sets. They formed a robust genomic analysis team and employed, validated, and published analysis methods in novel ways, with a focus on generating outcomes that were meaningful for public health, clinical medicine, and research.
New SARS-CoV-2 dashboards and websites
This project:
- Maintained an Arizona-wide dashboard to track virus genome sequencing, variant incidence, and the phytogeography of SARS-CoV-2 in Arizona.
- Generated websites to track the circulation and transmission of SARS-CoV-2, identify emerging mutations, capture phylogenetic trees and epidemiologic stories, and display an interactive dashboard.
New and improved sequencing software tools
This project further developed the Amplicon Sequencing Analysis Pipeline (ASAP) software for more rapid variant detection and mixture analysis via the TGen North ASAP Amplicon Sequencing Analysis Pipeline.
Content Source
Error processing SSI file
About This Page
Published: May 15, 2024
Updated: January 30, 2024
This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.
Reviewed: February 8, 2024
The information on this page was last reviewed by subject matter experts to ensure accuracy.